What question did this study set out to answer?

To comprehensively evaluate the clinical utility, benefits, and limitations of performing transesophageal echocardiography prior to cardioversion in patients with atrial fibrillation.

May 30, 2023CureusOpen Access

Transesophageal Echocardiogram Before Cardioversion in Atrial Fibrillation Patients

Q: What is the clinical evidence from this study?

Study design: Systematic Review. Population: Atrial Fibrillation. Intervention: Transesophageal echocardiography (TEE) before cardioversion. Primary outcome: Detection of left atrial thrombus and thromboembolic events.

View Full Paper

Ask AI

Bookmark

Key result

TEE-guided cardioversion effectively detects atrial thrombi to guide anticoagulation and prevent thromboembolic events.

Why the study?

Due to inconclusive data, the utility, potential benefits, and limitations of TEE prior to cardioversion in patients with AF remained ambiguous.

Does transesophageal echocardiography before cardioversion improve risk stratification for thromboembolic events in patients with atrial fibrillation?

Population

20 included studies in AF patients planned for cardioversion

Comparison

TEE before cardioversion

Authors

VAVictor O. AdedaraUniversity of Suffolk VSVagisha SharmaSUNY Upstate Medical University HNHassan NawazXiamen University

Discussion

Member takes

Implication

Supports TEE before AF cardioversion for thrombus detection; reinforces guideline utility without obviating periprocedural anticoagulation.

Key Points

To comprehensively evaluate the clinical utility, benefits, and limitations of performing transesophageal echocardiography prior to cardioversion in patients with atrial fibrillation.
Conducted a systematic literature search using keywords for atrial fibrillation, cardioversion, and transesophageal echocardiography across medical databases, identifying 640 initial records.
Screened 103 titles and abstracts and performed quality assessments to select 20 relevant studies: seven retrospective studies, 12 prospective observational studies, and one randomized controlled trial.
Left atrial appendage thrombus represents a definitive contraindication to cardioversion, whereas atrial sludge serves as a relative contraindication; contrast enhancement aids in accurate thrombus exclusion.
Post-cardioversion thromboembolic complications persist even in patients without detectable left atrial thrombi or sludge, often driven by post-procedure atrial stunning.
Evidence supports transesophageal echocardiography-guided direct-current cardioversion for risk stratification, especially in outpatient pathways, but mandates continued therapeutic anticoagulation during and after the procedure.

Study Design

Type

Systematic Review

Structured PICO

Does transesophageal echocardiography before cardioversion improve risk stratification for thromboembolic events in patients with atrial fibrillation?

Population

Patients with atrial fibrillation (AF) planned for cardioversion

Intervention

Transesophageal echocardiography (TEE) before cardioversion

Outcome

Detection of left atrial thrombus (LAT) or sludge, and incidence of thromboembolic events post-cardioversion

TEE before cardioversion is a valuable tool for detecting left atrial thrombus and stratifying thromboembolic risk in AF patients, though it does not obviate the need for periprocedural anticoagulation.

Limitations

Most included studies were observational (7 retrospective, 12 prospective), with only one randomized controlled trial.
Data on routine TEE before cardioversion remains inconclusive.
Further evidence is required to definitively establish atrial stunning post-cardioversion as a significant risk factor for future thromboembolic events.
Retrospective nature of some included studies
Single-center designs in some included studies
Small cohorts in some included studies
Limited follow-up duration in some included studies

Cite This Study

Adedara et al. (2023) conducted a systematic review in Atrial Fibrillation. Transesophageal echocardiography (TEE) before cardioversion was evaluated on Detection of left atrial thrombus and thromboembolic events. Transesophageal echocardiography-guided cardioversion effectively detects atrial thrombi prior to the procedure, aiding in risk stratification and guiding therapeutic anticoagulation to prevent thromboembolic events.

synapsesocial.com/papers/6a157ffeb2e0231f15829570 https://doi.org/10.7759/cureus.39702

Topics

Atrial fibrillation Persistent AF management Anticoagulation in AF AF ablation outcomes

View Full Paper

Ask AI

Bookmark

Implication

Supports TEE before AF cardioversion for thrombus detection; reinforces guideline utility without obviating periprocedural anticoagulation.

Transesophageal Echocardiogram Before Cardioversion in Atrial Fibrillation Patients

Discussion

Member takes

Implication

Key Points

Study Design

Structured PICO

Limitations

Cite This Study

Topics

Transesophageal Echocardiogram Before Cardioversion in Atrial Fibrillation Patients

Discussion

Member takes

Implication

Key Points

Study Design

Structured PICO

Limitations

Cite This Study

Also Consider

Topics

Also Consider